
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15253E8A8AF27973053E8A000C61E465.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis">
<meta name="citation_author" content="Hong Tham Pham">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam">
<meta name="citation_author_institution" content="Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam">
<meta name="citation_author" content="Manh Hung Tran">
<meta name="citation_author_institution" content="Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam">
<meta name="citation_author" content="Thuy-Van Mai Hoang">
<meta name="citation_author_institution" content="Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam">
<meta name="citation_author" content="Ai-Hoc Nguyen">
<meta name="citation_author_institution" content="Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam">
<meta name="citation_author" content="Minh-Hoang Tran">
<meta name="citation_author_institution" content="NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30742">
<meta name="citation_doi" content="10.1038/s41598-025-16062-w">
<meta name="citation_pmid" content="40841814">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/pdf/41598_2025_Article_16062.pdf">
<meta name="description" content="Evidence on the prevalence of HLA-B*58:01 genotyping and its association with allopurinol-induced severe cutaneous adverse reactions (SCARs) is lacking, especially in low-resource settings. We addressed these gaps by conducting comprehensive and ...">
<meta name="og:title" content="HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Evidence on the prevalence of HLA-B*58:01 genotyping and its association with allopurinol-induced severe cutaneous adverse reactions (SCARs) is lacking, especially in low-resource settings. We addressed these gaps by conducting comprehensive and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371011">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-16062-w"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_16062.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371011%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371011/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371011/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 21;15:30742. doi: <a href="https://doi.org/10.1038/s41598-025-16062-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-16062-w</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>HLA-B*58:01</em> genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pham%20HT%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hong Tham Pham</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Hong Tham Pham</span></h3>
<div class="p">
<sup>1</sup>Faculty of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam </div>
<div class="p">
<sup>2</sup>Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pham%20HT%22%5BAuthor%5D" class="usa-link"><span class="name western">Hong Tham Pham</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%20MH%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Manh Hung Tran</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Manh Hung Tran</span></h3>
<div class="p">
<sup>3</sup>Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%20MH%22%5BAuthor%5D" class="usa-link"><span class="name western">Manh Hung Tran</span></a>
</div>
</div>
<sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mai%20Hoang%20TV%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Thuy-Van Mai Hoang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Thuy-Van Mai Hoang</span></h3>
<div class="p">
<sup>3</sup>Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mai%20Hoang%20TV%22%5BAuthor%5D" class="usa-link"><span class="name western">Thuy-Van Mai Hoang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nguyen%20AH%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ai-Hoc Nguyen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ai-Hoc Nguyen</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nguyen%20AH%22%5BAuthor%5D" class="usa-link"><span class="name western">Ai-Hoc Nguyen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%20MH%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Minh-Hoang Tran</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Minh-Hoang Tran</span></h3>
<div class="p">
<sup>4</sup>NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%20MH%22%5BAuthor%5D" class="usa-link"><span class="name western">Minh-Hoang Tran</span></a>
</div>
</div>
<sup>4,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Faculty of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam </div>
<div id="Aff2">
<sup>2</sup>Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam </div>
<div id="Aff3">
<sup>3</sup>Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam </div>
<div id="Aff4">
<sup>4</sup>NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Apr 10; Accepted 2025 Aug 12; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371011  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841814/" class="usa-link">40841814</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Evidence on the prevalence of <em>HLA-B*58:01</em> genotyping and its association with allopurinol-induced severe cutaneous adverse reactions (SCARs) is lacking, especially in low-resource settings. We addressed these gaps by conducting comprehensive and race/ethnic origin-specific evaluations. We conducted a systematic search from inception to 31 December 2022 using databases (PubMed, Embase, and medRxiv), Google (for Vietnamese articles), and manual searching. We included original studies that investigated the association between <em>HLA-B*58:01</em> genotyping and allopurinol-induced SCARs. We excluded studies on: (1) animals; (2) pharmacokinetics/pharmacodynamics; (3) genetic markers or genetic testing methods; (4) single group; and (5) cost-effectiveness of screening. Risk of bias was assessed using Newcastle–Ottawa Scale. We used random-effects model to report the summary estimates and 95% confidence interval (95% CI) in the meta-analysis. We included 13,719 patients from 24 case–control studies. The prevalences of <em>HLA-B*58:01</em> genotyping (overall 5.8%; 95% CI 2.9% to 11.5%; I<sup>2</sup> = 98%) varied by races (Asian [7.7%; 95% CI 3.4% to 16.8%; I<sup>2</sup> = 98%] and White in Eastern/Western Europe [2.3%; 95% CI 1.2% to 4.3%; I<sup>2</sup> = 86%]) and ethnic origins (East and Central Asia [5.5%; 95% CI 1.5% to 17.8%; I<sup>2</sup> = 98%] and South and Southeast Asia [12.9%; 95% CI 9.5% to 17.3%; I<sup>2</sup> = 79%]). <em>HLA-B*58:01</em> genotyping was associated with substantially increasing risk of allopurinol-induced SCARs (odds ratio 117.6; 95% CI 70.3 to 196.8; I<sup>2</sup> = 45%) regardless of the subgroups. We found a higher prevalence of <em>HLA-B*58:01</em> genotyping in some Asian populations compared with the Whites. There is evidence to confirm a strong association between this allele and allopurinol-induced SCARs.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1038/s41598-025-16062-w.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> <em>HLA-B*58:01</em>, Allopurinol, Drug hypersensitivity, Severe cutaneous adverse reaction</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Genetics, Immunology, Risk factors</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par21">Allopurinol is widely prescribed as a first-line treatment for gout and hyperuricaemia due to its urate-lowering efficacy. However, its use has been associated with the development of severe cutaneous adverse reactions (SCARs), which can pose significant risks of morbidity and mortality<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. SCARs can present with extensive skin and mucosal involvement (e.g., rash, erythematous or purpuric macules, blistering, epidermal detachment), systemic symptoms (e.g., fever, organ failure), or laboratory abnormalities (e.g., eosinophilia, neutrophilia)<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>.</p>
<p id="Par22">The <em>HLA-B*58:01</em> allele has been identified as a strong genetic risk factor for the development of allopurinol-induced SCARs<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>. The association between this allele and allopurinol-induced SCARs was reportedly observed in some Western and Asian populations, including Han Chinese, Japanese, Korean, or Thai<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Mechanistically, allopurinol is metabolised into oxypurinol, its active metabolite. In individuals carrying the <em>HLA-B*58:01</em> allele, oxypurinol can bind non-covalently to the peptide-binding groove of the <em>HLA-B*58:01</em> molecule on antigen-presenting cells. This alters the peptide repertoire or presents a novel complex that is recognised as foreign by CD8<sup>+</sup> T cells, triggering a cytotoxic T-cell response<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>. These findings have led some countries to recommend <em>HLA-B*58:01</em> screening before initiating allopurinol therapy in populations with a high prevalence of this allele<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>, which was shown to be cost-effective in some settings<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>.</p>
<p id="Par23">Despite the growing body of evidence, there remains an inconsistency among findings from different settings and a lack of race/ethnic origin-specific prevalence of <em>HLA-B*58:01</em> genotyping<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. These issues are likely due to: (1) biases from studies with lower levels of evidence (case–control study-based findings) and (2) new data not being consolidated. This gap could limit the <em>HLA-B*58:01</em> screening and other preventive measures in high-risk populations, especially in low- and middle-income Asian countries.</p>
<p id="Par24">Given the lack of high-quality evidence in these low-resource settings, we planned to continuously consolidate new data on the prevalence of <em>HLA-B*58:01</em> genotyping and its association with allopurinol-induced SCARs. We aimed to provide more precise and race/ethnic origin-specific estimates to better address the genetic variation related to allopurinol-induced SCARs. Our goal was to improve patient safety by identifying other populations at high risk for allopurinol-induced SCARs and providing evidence to implement preventive measures in these groups efficiently.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design and reporting standards</h3>
<p id="Par25">We used the methods and recommendations in the Cochrane Handbook for Systematic Reviews of Interventions<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>, with some adjustments for our exposure of interest. The protocol for this review was registered and stored at the Open Science Framework (OSF) Registries<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement to report this review<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. The PRISMA checklist was presented in eTables 1 and 2 (Supplementary Data).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Selection criteria</h3>
<section id="Sec5"><h4 class="pmc_sec_title">Types of studies</h4>
<p id="Par26">We included all original studies that investigated the association between <em>HLA-B*58:01</em> genotyping and allopurinol-induced SCARs. The following formats were considered for inclusion: full-text publications, preprints, and conference abstracts. We did not set any restrictions for languages of publication, provided that there was an English abstract. We excluded reports that were: (1) studies on animals; (2) pharmacokinetic/pharmacodynamic studies; (3) studies that investigated genetic markers or genetic testing methods; (4) non-comparative epidemiological studies (e.g., case reports or case series); and (5) cost-effectiveness of screening studies that did not address the association between or prevalences of <em>HLA-B*58:01</em> and allopurinol-induced SCARs.</p></section><section id="Sec6"><h4 class="pmc_sec_title">Types of patients</h4>
<p id="Par27">We included 2 cohorts: (1) hospital-based adults who were treated with allopurinol and were tested for the <em>HLA-B*58:01</em> genotyping (cohort 1, including SCAR group and tolerant group); and (2) population-based adults who were not treated with allopurinol but were tested for the <em>HLA-B*58:01</em> genotyping (cohort 2, population group). The settings of these cohorts (time and place) were from the individual studies. Where being approved, patients taking oxypurinol—a metabolite of allopurinol that has been made as a medication—were also considered. Unless provided in the demographic information, the races and ethnic origins of the patients were identified based on the study settings. Races and ethnic origins (or ethnicities) were defined using conventional concepts<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>. We excluded studies that evaluated patients who: (1) received allopurinol for ≤ 2 days; (2) were taking any new medications during the data collection timeframe of the studies; or (3) had a history of SCARs.</p></section><section id="Sec7"><h4 class="pmc_sec_title">Types of outcome measures</h4>
<p id="Par28">We investigated different syndromes of SCARs, including acute generalised exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and Stevens–Johnson/toxic epidermal necrolysis overlap syndrome (SJS/TEN). Studies reporting severe symptoms of maculopapular eruption/exanthema (MPE) or erythema multiforme major (EMM) were also included. We excluded studies using patient-reported outcomes for SCAR diagnosis or where SCAR diagnosis was not verified by a dermatologist.</p></section></section><section id="Sec8"><h3 class="pmc_sec_title">Data sources and search strategy</h3>
<p id="Par29">We conducted systematic searches on PubMed (pubmed.ncbi.nlm.nih.gov), Embase (embase.com), and medRxiv (medrxiv.org) databases from inception. With a living systematic review/meta-analysis design, 5 repeated searches were performed between 1 June 2020 and 31 December 2022 (the latter was the date of the last search for 3 databases). At the last search, we also checked if any of the included preprints were published to retrieve the most updated information. We searched for articles that were published in Vietnamese using Google (google.com). Additionally, a manual search for references in relevant review articles was performed. Details of the search strategy were provided in eTable 3 (Supplementary Data). We detected and removed duplicate references using EndNote (version 19, The EndNote Team, Clarivate, Pennsylvania, United States of America).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Data collection</h3>
<section id="Sec10"><h4 class="pmc_sec_title">Selection of studies</h4>
<p id="Par30">Initially, 2 authors (HTP and T-VMH) independently reviewed the results of the systematic searches for inclusion. After screening the abstracts, the 2 reviewing authors classified the studies as “included” or “excluded”. If there was any disagreement after the first round of screening, the 2 reviewing authors re-assessed the full-text version in a discussion. When they could not reach a consensus, 1 other author (M-HT) was consulted for the final decision.</p></section><section id="Sec11"><h4 class="pmc_sec_title">Risk of bias assessment</h4>
<p id="Par31">According to our last search, no randomised controlled trials were relevant or eligible for inclusion. Thus, we decided to use the Newcastle–Ottawa Scale (NOS) to assess the risk of bias of the included studies<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>, which was conducted independently by 2 authors (HTP and MHT). Any discrepancies after the first round of quality assessment were discussed among the 2 initial evaluators and a third author (M-HT) before reaching the final decisions. As all included studies had a case–control design, we assessed the risk of bias based on the following categories: selection (4 items, maximum score of 4), comparability (1 item, maximum score of 2), and exposure (3 items, maximum score of 3). Regarding the NOS, there is currently no established threshold for the total score to distinguish studies with low and high risk of bias<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. In this review, using a conventional cut-off<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>, we proposed that studies with NOS score ≤ 3 implied a high risk of bias. We presented the scores of the NOS for all included studies in eTable 4 (Supplementary Data).</p></section><section id="Sec12"><h4 class="pmc_sec_title">Data extraction and management</h4>
<p id="Par32">Initially, 2 authors (T-VMH and A-HN) independently conducted data extraction based on the recommendations of Cochrane<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. We used a piloted and standardised form to extract the following information, where appropriate: (1) general information (author; title; publication date, format, and language; country); (2) study design (type; setting; date; inclusion/exclusion criteria; comparability of study groups; outcome measurement); (3) patient characteristics (age; sex; race; ethnic origin; number of patients recruited/investigated; <em>HLA-B*58:01</em> genotyping); and (4) outcomes (syndromes of SCARs). Any disagreements, if not being solved in discussions, were determined by a third author (M-HT). If the studies were not reported in English or Vietnamese, we sent the copies to a certified agency for translation. Missing data were obtained either by computing from available information or contacting the primary investigators, where appropriate.</p></section></section><section id="Sec13"><h3 class="pmc_sec_title">Data analysis</h3>
<section id="Sec14"><h4 class="pmc_sec_title">Exposure and outcome measurement</h4>
<p id="Par33">For the measurement of the <em>HLA-B*58:01</em> allele (dichotomous exposure) and SCARs (dichotomous outcomes), we recorded the number of exposed patients, number of events, and total number of patients of the included studies. The pooled prevalence of <em>HLA-B*58:01</em> genotyping was reported with the 95% confidence interval (95% CI). For the association between <em>HLA-B*58:01</em> genotyping and SCARs, we reported the pooled odds ratio (OR) with the 95% CI.</p></section><section id="Sec15"><h4 class="pmc_sec_title">Heterogeneity assessment</h4>
<p id="Par34">We assessed the heterogeneity among the studies both visually (using forest plots) and statistically (using Chi-squared tests with a significance level of 0.05). The levels of heterogeneity were investigated with the I<sup>2</sup> statistic, based on the following convention: I<sup>2</sup> statistic &gt; 75% implying considerable heterogeneity<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. We pre-specified subgroup analyses for all measurements to explore the patterns of heterogeneity. In case of high likelihood of heterogeneity, we decided to conduct the meta-analysis, as the pooled results were still more beneficial than individual reports from case–control studies. However, from our perspectives, these findings were considered exploratory only.</p></section><section id="Sec16"><h4 class="pmc_sec_title">Reporting bias assessment</h4>
<p id="Par35">We clarified the potential reporting bias visually with the funnel plot and statistically with Egger’s test at a significance level of 0.05<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. As assessing the funnel plot was subjective and the low power of Egger’s test cannot reliably rule out reporting bias<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>, all 5 authors (HTP, T-VMH, M-HT, A-HN, and MHT) independently assessed both of these results to reach a final decision. If the funnel plots revealed asymmetry, we attempted to differentiate reporting bias from other potential sources of asymmetry. In these cases, we used contour-enhanced funnel plots with significance levels of 0.01, 0.05, and 0.1<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>.</p></section></section><section id="Sec17"><h3 class="pmc_sec_title">Data synthesis</h3>
<p id="Par36">We pooled the data in the meta-analysis using random-effects model with the inverse variance approach, as we had expected some degrees of heterogeneity. We conducted all data syntheses and statistical analyses using R software (version 4.2.1, R Foundation for Statistical Computing, Vienna, Austria). We used the <em>metafor</em> package for the meta-analysis and <em>forestploter</em> to draw the forest plots of the pooled results<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>,<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>.</p>
<p id="Par37">We estimated the pooled prevalence of <em>HLA-B*58:01</em> genotyping in 3 populations: (1) allopurinol-induced SCAR group (from cohort 1); (2) allopurinol-tolerant group (from cohort 1); and (3) population group (from cohort 2). The pooled ORs for the exposure (<em>HLA-B*58:01</em> positive or negative) and outcome of interest (SCARs) were reported for cohort 1. The subgroup analysis was pre-specified after data extraction and was conducted based on the following factors: race (Asian or White) and ethnic origin (Eastern and Western Europe, East and Central Asia, or South and Southeast Asia). For studies reporting multi-racial or multi-ethnic information, we classified them based on the dominant race and ethnic origin. For exploratory purposes, the prevalences of <em>HLA-B*58:01</em> genotyping in 5 Asian ethnicities (Han Chinese, Japanese, Korean, Thai, and Vietnamese) were estimated a posteriori. We performed the sensitivity analyses to investigate: (1) the differences between fixed-effect and random-effects models and (2) the pooled results after excluding studies with a high risk of bias (using the conventional cut-off of NOS score ≤ 3<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>).</p></section></section><section id="Sec18"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec19"><h3 class="pmc_sec_title">Searching results</h3>
<p id="Par38">We searched and identified 528 records from the databases/registers and 44 records from citation searching, websites, and Vietnamese medical journals (Ho Chi Minh City Journal of Medicine [ISSN 1859-1779], Journal of 108-Clinical Medicine and Pharmacy [ISSN 1859-2872], Journal of Clinical Medicine [ISSN 1859-3593], Journal of Medical Research [ISSN 2354-080X], Journal of Medicine and Pharmacy [ISSN 2734-9209], MedPharmRes [eISSN 2615-9139], Vietnam Journal of Preventive Medicine [ISSN 0868-2836], and Vietnam Medical Journal [ISSN 1859-1868]). After screening for eligibility, we included 24 reports (from 24 studies) in this review (Table <a href="#Tab1" class="usa-link">1</a>). The specific number of records identified, included and excluded, and the reasons for exclusions are presented in the PRISMA flow diagram (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Characteristics of included studies.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Study</th>
<th align="left" colspan="1" rowspan="1">Characteristics</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="2" rowspan="1">Bardin, 2018</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (abstract)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication year (language): 2018 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Vietnam</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 10 in SCAR group, 112 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 55 (SD 12) in SCAR group, mean 46 (SD 12) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 2/10 (20%) in SCAR group, 0/112 (0%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnic origin: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): mean 345 (SD 142) in SCAR group, mean 356 (SD 114) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Cao, 2012</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication year (language): 2012 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: China</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 38 in SCAR group, 63 in tolerant group, 572 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 63.8 (SD 14.4) in SCAR group, mean 60.9 (SD 15.1) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 12/38 (31.6%) in SCAR group, 6/63 (9.5%) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnic origin: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 300 (IQR 100–600) in SCAR group, not clearly reported in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): mean 26.2 (SD 13.5) in SCAR group, mean 122.7 (SD 11.6) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, MPE, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Cheng, 2015</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication year (language): 2015 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: China</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: (1) were Han Chinese; (2) used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: had history of bone marrow transplantation, chemotherapy or cancer</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 92 in SCAR group, 75 in tolerant group, 99 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 59.1 (SD 1.6) in SCAR group, mean 53.4 (SD 1.5) in tolerant group, mean 49.3 (SD 0.6) in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 32/92 (34.8%) in SCAR group, 4/75 (5.3%) in tolerant group, 35/99 (35.4%) in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnic origin: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): mean 186.5 (SD 13.7) in SCAR group, mean 289.8 (SD 15.2) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): mean 22.0 (SD 1.5) in SCAR group, mean 1153.4 (SD 303.0) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Chiu, 2012</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2012 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: China</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: were not Han Chinese</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 20 in SCAR group, 30 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 68.5 (IQR 33–96) in SCAR group, median 71.5 (IQR 41–97) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 9/20 (45.0%) in SCAR group, 4/30 (13.3%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnic origin: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 250 (IQR 100–600) in SCAR group, median 200 (IQR 100–300) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): median 24.5 (IQR 10–56) in SCAR group, median 1620 (365–5400) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, EMM, SJS, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Cristallo, 2011</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2011 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Italy</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: White (Northern Italy)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not clearly reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 7 in SCAR group, 115 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age: mean 64.0 (SD 9.7) in SCAR group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 4/7 (57.1%) in SCAR group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: White</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnic origin: Eastern/Western Europe</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Do, 2015</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2015 (Vietnamese)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Vietnam</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 22 in SCAR group, 75 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (&gt; 60 years): 10/22 (45.5%) in SCAR group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 11/22 (50.0%) in SCAR group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnic origin: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 300 (IQR 300–300) in SCAR group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, MPE, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Do, 2019</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2019 (Vietnamese)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Vietnam</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: (1) had gout; (2) used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: (1) using medications with high risk of allergy; (2) prior intermittent use of allopurinol</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 7 in SCAR group, 128 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age: mean 49.0 in SCAR group, mean 46.3 in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 2/7 (28.6%) in SCAR group, 0/128 (0.0%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 300 in SCAR group, median 300 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): median 18 in SCAR group, median 260.5 in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Do, 2020</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2020 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Vietnam</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 31 in SCAR group, 395 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 60.0 (SD 15.9) in SCAR group, mean 45.4 (SD 10.3) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 9/31 (29.0%) in SCAR group, 0/395 (0.0%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): mean 303.4 (SD 97.2) in SCAR group, mean 369.1 (SD 103.8) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Gonçalo, 2013</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2013 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Portugal</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 25 in SCAR group, 23 in tolerant group, 3200 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 67.4 (SD 16.0) in SCAR group, mean 62.0 in tolerant group, mean 32.0 in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 14/25 (56.0%) in SCAR group, 7/23 (30.4%) in tolerant group, 65% in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: White</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: Eastern/Western Europe</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 300 in SCAR and tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): &gt; 4 months in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Hung, 2005</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2005 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Taiwan</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 51 in SCAR group, 135 in tolerant group, 93 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 66 (IQR 18–91) in SCAR group, median 56 (IQR 21–84) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 27/51 (52.9%) in SCAR group, 10/135 (7.4%) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 100 (IQR 50–300) in SCAR group, median 150 (IQR 100–400) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): median 26 (IQR 1–56) in SCAR group, median 22 (IQR 6–107) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Jung, 2011</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2011 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: South Korea</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: (1) had chronic kidney disease stage 3–5 or post-kidney transplantation; (2) used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: used allopurinol for &lt; 60 days in tolerant group</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 9 in SCAR group, 432 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 41.6 (SD 15.9) in SCAR group, mean 35.9 (SD 18.1) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 3/9 (33.3%) in SCAR group, 114/432 (26.4%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): mean 112.5 (SD 38.7) in SCAR group, mean 100 (SD 50.1) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): mean 59.1 (SD 45.5) in SCAR group, mean 887.1 (SD 821.3) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Kang, 2011</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2011 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: South Korea</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: not clearly reported (for tolerant group: chronic kidney disease)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 25 in SCAR group, 57 in tolerant group, 485 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 58 (IQR 35–80) in SCAR group, median 51 (IQR 20–76) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 11/25 (44.0%) in SCAR group, 20/57 (35.1%) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 150 (IQR 100–600) in SCAR group, median 100 (IQR 50–200) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (months): median 1.0 (IQR 0.2–5.3) in SCAR group, median 29.1 (IQR 6–72) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Kaniwa, 2008</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2008 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Japan</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: not reported</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 10 in SCAR group, 493 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 74 (IQR 67–76.5) in SCAR group, not reported in other groups</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 2/10 (20.0%) in SCAR group, not reported in other groups</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Lonjou, 2008</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2008 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: European countries</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 31 in SCAR group, 1822 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 56 (IQR 40–71.5) in SCAR group, not reported in other groups</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 13/31 (41.9%) in SCAR group, not reported in other groups</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: White (87.1%), Asian (6.5%), African (3.2%), South American (3.2%)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: Eastern/Western Europe</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Low, 2020</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2020 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Malaysia</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: (1) aged ≥ 18; (2) used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 55 in SCAR group, 42 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 64.9 in SCAR group, mean 59.9 in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): not reported</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia (59.8%), East and Central Asia (40.2%)</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">AGEP, DRESS, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Ng, 2016</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2016 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Taiwan</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hopsital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 146 in SCAR group, 285 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 65 (SD 16) in SCAR group, mean 59 (SD 14) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 66/146 (45.2%) in SCAR group, 17/285 (6.0%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, DRESS/SJS/TEN, MPE, SJS, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Nguyen, 2021</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2021 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Vietnam</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 81 in SCAR group, 74 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 57.6 (SD 14.6) in SCAR group, mean 60.3 (SD 11.4) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 20/81 (24.7%) in SCAR group, 9/74 (12.2%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): mean 324.7 (SD 121.0) in SCAR group, mean 281.8 (SD ) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">AGEP/SJS, DRESS, DRESS/SJS/TEN, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Niihara, 2013</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2013 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Japan</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 7 in SCAR group, 25 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 72 (IQR 68.5–78.5) in SCAR group, not reported in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 2/7 (28.6%) in SCAR group, not reported in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, EMM</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Park, 2016</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2016 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: South Korea</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 9 in SCAR group, 949 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): not reported</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): not reported</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Pham, 2022</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2022 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Vietnam</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: (1) bullous autoimmune skin diseases; (2) erythema multiforme/erythema infectiosum; (3) Kawasaki disease; (4) bone marrow transplantation; (5) acropustulosis; (6) Von Zumbusch psoriasis; and (7) concomitant use of another drug of high allergy potential at SCARs onset</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 100 in SCAR group, 183 in tolerant group, 810 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 58.5 (SD 14.2) in SCAR group, mean 55.2 (SD 12.2) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 24/100 (24.0%) in SCAR group, 29/183 (15.8%) in tolerant group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (&gt; 150 mg/day): 96/100 (96.0%) in SCAR group, 164/183 (89.6%) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): not reported</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, DRESS/SJS/TEN, SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Saksit, 2017</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2017 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Thailand</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 86 in SCAR group, 182 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 68 (IQR 28–84) in SCAR group, median 66 (IQR 29–91) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 45/86 (52.3%) in SCAR group, 39 (21.4%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): median 100 (IQR 50–300) in SCAR group, median 100 (IQR 50–400) in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): median 19 (IQR 2–60) in SCAR group, median not reported in tolerant group (mean &gt; 180)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Sukasem, 2016</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication date (language): 2016 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Thailand</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 30 in SCAR group, 100 in tolerant group, 1095 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 73 (IQR 30–88) in SCAR group, not reported in other groups</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 13/30 (43.3%) in SCAR group, not reported in other groups</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): mean 239.9 (SD 87.0) in SCAR group, not reported in other groups</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): mean 16.4 (SD 14.3), not reported in other groups</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">DRESS, MPE, SJS/TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Tassaneeyakul, 2009</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication year (language): 2009 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Thailand</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: (1) used allopurinol; (2) agreed to participate</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 27 in SCAR group, 54 in tolerant group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): median 65 (IQR 38–81) in SCAR group, median 63.5 (IQR 46–90) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 12/27 (44.4%) in SCAR group, 11/54 (20.4%) in tolerant group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: South and Southeast Asian</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): median 14 (IQR 3–50) in SCAR group, median 780 (IQR 90–18,000) in tolerant group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, SJS/TEN, TEN</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Tohkin, 2013</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1"> General information</td>
<td align="left" colspan="1" rowspan="1">Publication format: journal publication (full-text)</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Publication year (language): 2013 (English)</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Country: Japan</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1"> Design</td>
<td align="left" colspan="1" rowspan="1">Type: case–control study</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Setting: hospital and population</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Inclusion criteria: for hospital setting: used allopurinol</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Exclusion criteria: not reported</td></tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Patient demographics</td>
<td align="left" colspan="1" rowspan="1">Number of patients investigated: 18 in SCAR group, 986 in population group</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Age (years): mean 72.3 (SD 10.0) in SCAR group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Sex (female): 6/18 (33.3%) in SCAR group, not reported in population group</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Race: Asian</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Ethnicity: East and Central Asia</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Exposure</td>
<td align="left" colspan="1" rowspan="1">Dosing of allopurinol (mg/day): not reported</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Duration of allopurinol (days): mean 21.7 (SD 11.9), not reported in population group</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Outcomes</td>
<td align="left" colspan="1" rowspan="1">SJS, TEN</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p22">
<p>AGEP: acute generalised exanthematous pustulosis; DRESS: drug reaction with eosinophilia and systemic symptoms; EMM: erythema multiforme major; IQR: interquartile range; MPE: maculopapular eruption; SCAR: severe cutaneous adverse reaction; SD: standard deviation; SJS: Stevens–Johnson syndrome; SJS/TEN: Stevens–Johnson/toxic epidermal necrolysis overlap syndrome; and TEN: toxic epidermal necrolysis (TEN).</p>
<p>In the context of SCARs, DRESS can also be referred as drug hypersensitivity syndrome (DHS), drug-induced hypersensitivity syndrome (DIHS), or hypersensitivity syndrome (HSS). To ensure consistency, outcomes that were reported as DHS, DIHS, or HSS were classified as DRESS.</p>
</div></div></section><figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371011_41598_2025_16062_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/12371011/0995e400a32b/41598_2025_16062_Fig1_HTML.jpg" loading="lazy" id="d33e2033" height="488" width="750" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PRISMA flow diagram.</p></figcaption></figure></section><section id="Sec20"><h3 class="pmc_sec_title">Descriptive characteristics</h3>
<section id="Sec21"><h4 class="pmc_sec_title">Study design and setting</h4>
<p id="Par39">All 24 reports were case–control studies. Among these, 5 studies did not have well-defined study bases for population-based control selection<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>, 12 studies inappropriately compared cases with population-based or genomic database controls without prior exposure to allopurinol<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>,<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>. No studies used matching to control for potential confounders, while 5 studies used clearly defined multivariable regression modelling to report confounder-adjusted OR<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>–<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. There were 3 studies on the White population from Europe, 11 studies on Asians from East and Central Asia and 10 studies on Asians from South and Southeast Asia. For Asia-based studies, 6 were conducted in Vietnam, 5 in China/Taiwan, 3 in Japan, 3 in South Korea, and 3 in Thailand. Most studies were conducted at multiple centres.</p></section><section id="Sec22"><h4 class="pmc_sec_title">Patient characteristics</h4>
<p id="Par40">We included 13,719 observations from 24 studies (937 in SCAR group, 3344 in tolerant group, and 9352 in population group). People in the tolerant group (2 studies with mean/median age of 65 or more) were probably younger than those in the SCAR group (10 studies with mean/median age of 65 or more). Compared with males, females were less likely to experience SCAR or be included as tolerant controls in most studies. The mean/median dose of ≥ 200 mg of allopurinol was reported in most studies (9 out of 14 studies). Demographic information was not adequately reported in the population group.</p></section><section id="Sec23"><h4 class="pmc_sec_title">Exposure</h4>
<p id="Par41"> All studies used polymerase chain reaction (PCR) for <em>HLA-B*58:01</em> genotyping. In particular, there were 3 primary techniques being used to determine the <em>HLA-B*58:01</em> genotype, i.e., sequence-specific primers, sequence-specific oligonucleotide, and sequence-based typing. However, for most studies investigating the population-based control group, genotyping techniques were not clearly reported.</p></section><section id="Sec24"><h4 class="pmc_sec_title">Outcomes</h4>
<p id="Par42">Most studies used RegiSCAR, Roujeau, or Bastuji-Garin criteria to confirm SCAR diagnoses. The most frequently investigated SCAR was SJS/TEN (reported in 18 studies), followed by SJS and DRESS (reported in 15 and 14 studies, respectively). We also recorded 10 studies reporting TEN, 4 studies reporting severe MPE, 2 studies reporting EMM, and 1 study reporting AGEP. Among 937 cases, the prevalences of 5 primary syndromes of SCARs were as follows (in decreasing order): DRESS (36.4%), SJS (29.2%), SJS/TEN (18.4%), TEN (6.9%), and AGEP (0.1%). Besides SJS/TEN, 2 other overlap syndromes were also reported, including AGEP/SJS<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup> and DRESS/SJS/TEN<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>.</p></section></section><section id="Sec222"><h3 class="pmc_sec_title">Prevalence of <em>HLA-B*58:01</em>
</h3>
<section id="Sec25"><h4 class="pmc_sec_title">In allopurinol-induced SCAR group</h4>
<p id="Par43">All 24 studies reported the prevalence of <em>HLA-B*58:01</em> genotyping in the allopurinol-induced SCAR group<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Among 937 patients with allopurinol-induced SCARs, 837 tested positive for <em>HLA-B*58:01</em>. The pooled prevalence of <em>HLA-B*58:01</em> genotyping in this group was 88.5% (95% CI 81.3% to 93.1%; I<sup>2</sup> = 80%; Fig. <a href="#Fig2" class="usa-link">2</a>). We also found some discrepancies among different races and ethnic origins. We detected a higher prevalence of <em>HLA-B*58:01</em> genotyping in the Asian sub-population (91.1%; 95% CI 85.4% to 94.8%; I<sup>2</sup> = 73%; Fig. <a href="#Fig2" class="usa-link">2</a>A) than that in the White from Eastern or Western Europe (60.3%; 95% CI 47.7% to 71.6%; I<sup>2</sup> = 0%; Fig. <a href="#Fig2" class="usa-link">2</a>). In Asian settings, 87.7% (95% CI 73.3% to 94.9%; I<sup>2</sup> = 82%; Fig. <a href="#Fig2" class="usa-link">2</a>B) of people with allopurinol-induced SCARs in East and Central Asia tested positive for <em>HLA-B*58:01</em>, whereas the estimate for people in South and Southeast Asia was 93.4% (95% CI 90.5% to 95.4%; I<sup>2</sup> = 0%; Fig. <a href="#Fig2" class="usa-link">2</a>B). Results of the sensitivity analyses were comparable to that of the primary analysis (eFig. 1–4, Supplementary Data).</p>
<figure class="fig xbox font-sm" id="Fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371011_41598_2025_16062_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/12371011/867f0e235343/41598_2025_16062_Fig2_HTML.jpg" loading="lazy" id="d33e2210" height="489" width="750" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pooled prevalence of <em>HLA-B*58:01</em> genotyping in the allopurinol-induced SCAR group. Abbreviations: 95% CI, 95% confidence interval; IV, inverse variance; NOS, Newcastle–Ottawa Scale (C, comparability; E, exposure; S, selection; T, total); SCAR, severe cutaneous adverse reaction. The pooled prevalence of <em>HLA-B*58:01</em> was stratified by race (Panel <strong>A</strong>) and by ethnic origin (Panel <strong>B</strong>). We fitted the normal-normal random-effects model with restricted maximum likelihood estimator, using logit transformation and inverse logit back-transformation.</p></figcaption></figure></section><section id="Sec26"><h4 class="pmc_sec_title">In allopurinol-tolerant group</h4>
<p id="Par44">We identified 19 studies reporting the prevalence of <em>HLA-B*58:01</em> genotyping in the allopurinol-tolerant group<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>–<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>–<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Among 3344 allopurinol-tolerant people, 360 tested positive for <em>HLA-B*58:01</em>. The pooled prevalence of <em>HLA-B*58:01</em> genotyping in this group was 10.5% (95% CI 8.8% to 12.4%; I<sup>2</sup> = 53%; Fig. <a href="#Fig3" class="usa-link">3</a>). There was no significant difference among races and ethnic origins (Fig. <a href="#Fig3" class="usa-link">3</a>). The sensitivity analyses also showed similar findings (eFig. 5–8, Supplementary Data).</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371011_41598_2025_16062_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/12371011/228e30b2dd97/41598_2025_16062_Fig3_HTML.jpg" loading="lazy" id="d33e2278" height="445" width="750" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pooled prevalence of <em>HLA-B*58:01</em> genotyping in the allopurinol-tolerant group. Abbreviations: 95% CI, 95% confidence interval; IV, inverse variance; NOS, Newcastle–Ottawa Scale (C, comparability; E, exposure; S, selection; T, total). The pooled prevalence of <em>HLA-B*58:01</em> was stratified by race (Panel <strong>A</strong>) and by ethnic origin (Panel <strong>B</strong>). We fitted the normal-normal random-effects model with restricted maximum likelihood estimator, using logit transformation and inverse logit back-transformation.</p></figcaption></figure></section><section id="Sec27"><h4 class="pmc_sec_title">In population group</h4>
<p id="Par45">We identified 12 studies reporting the prevalence of <em>HLA-B*58:01</em> genotyping in the population group<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>,<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>,<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>. Among 9352 healthy people, 505 tested positive for <em>HLA-B*58:01</em>. The pooled prevalence of <em>HLA-B*58:01</em> genotyping in this group was 5.8% (95% CI 2.9% to 11.5%; I<sup>2</sup> = 98%; Fig. <a href="#Fig4" class="usa-link">4</a>). There was a high degree of heterogeneity between races (Asian and White; Fig. <a href="#Fig4" class="usa-link">4</a>A), which could be due to the heterogeneity in East and Central Asia populations (Fig. <a href="#Fig4" class="usa-link">4</a>B). The prevalence of <em>HLA-B*58:01</em> genotyping in South and Southeast Asia (12.9%; 95% CI 9.5% to 17.3%; I<sup>2</sup> = 79%; Fig. <a href="#Fig4" class="usa-link">4</a>B) was higher than that in Eastern and Western Europe (2.3%; 95% CI 1.2% to 4.3%; I<sup>2</sup> = 86%; Fig. <a href="#Fig4" class="usa-link">4</a>B). We also found similar results in the sensitivity analyses (eFig 10–13, Supplementary Data). For Asian population, <em>HLA-B*58:01</em> genotyping was more frequent in people of Han Chinese, Korean, Thai, and Vietnamese descent than in the Japanese (eFig. 9, Supplementary Data).</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371011_41598_2025_16062_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/12371011/568f763aa94f/41598_2025_16062_Fig4_HTML.jpg" loading="lazy" id="d33e2366" height="371" width="751" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pooled prevalence of <em>HLA-B*58:01</em> genotyping in the population group. Abbreviations: 95% CI, 95% confidence interval; IV, inverse variance; NOS, Newcastle–Ottawa Scale (C, comparability; E, exposure; S, selection; T, total). The pooled prevalence of <em>HLA-B*58:01</em> was stratified by race (Panel <strong>A</strong>) and by ethnic origin (Panel <strong>B</strong>). We fitted the normal-normal random-effects model with restricted maximum likelihood estimator, using logit transformation and inverse logit back-transformation.</p></figcaption></figure></section></section><section id="Sec28"><h3 class="pmc_sec_title">Association between <em>HLA-B*58:01</em> and allopurinol-induced SCARs</h3>
<p id="Par46">We identified 19 studies investigating the association between <em>HLA-B*58:01</em> genotyping and allopurinol-induced SCARs<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>–<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>–<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Having <em>HLA-B*58:01</em> genotyping was associated with substantially increasing risk of allopurinol-induced SCARs (pooled OR 117.6; 95% CI 70.3 to 196.8; I<sup>2</sup> = 45%; Fig. <a href="#Fig5" class="usa-link">5</a>). No subgroup differences were detected (Fig. <a href="#Fig5" class="usa-link">5</a>). Result of Egger’s test implied asymmetry (p &lt; 0.001), and this was likely due to publication bias (eFig. 18, Supplementary Data). The sensitivity analyses implied similar findings (eFig. 14–17, Supplementary Data).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371011_41598_2025_16062_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/12371011/f9926e456ecd/41598_2025_16062_Fig5_HTML.jpg" loading="lazy" id="d33e2432" height="1239" width="786" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Association between <em>HLA-B*58:01</em> genotyping and allopurinol-induced SCARs. Abbreviations: 95% CI, 95% confidence interval; IV, inverse variance; NOS, Newcastle–Ottawa Scale (C, comparability; E, exposure; S, selection; T, total); OR: odds ratio. The pooled OR was stratified by race (Panel <strong>A</strong>) and by ethnic origin (Panel <strong>B</strong>). We fitted the normal-normal random-effects model with restricted maximum likelihood estimator, using logit transformation and inverse logit back-transformation.</p></figcaption></figure></section></section><section id="Sec29"><h2 class="pmc_sec_title">Discussion</h2>
<section id="Sec30"><h3 class="pmc_sec_title">Summary of main results</h3>
<p id="Par47">We included 24 studies, with a total of 937 individuals with allopurinol-induced SCARs, 3344 allopurinol-tolerant individuals, and 9352 healthy individuals from the populations. The pooled prevalences of <em>HLA-B*58:01</em> genotyping in the allopurinol-induced SCAR group, allopurinol-tolerant group, and population group were 88.5%, 10.5%, and 5.8%, respectively. Compared with the Whites in Eastern and Western Europe, Asian populations had higher prevalences of <em>HLA-B*58:01</em> genotyping and had a greater risk for allopurinol-induced SCARs. Within the Asian settings, <em>HLA-B*58:01</em> genotyping was more frequently detected in people of Han Chinese, Korean, Thai, and Vietnamese descent than in the Japanese.</p></section><section id="Sec31"><h3 class="pmc_sec_title">Overall completeness and applicability of evidence</h3>
<p id="Par48">We identified a lack of evidence for the following commonly-reported races and ethnic origins: (1) races: Pacific Islander, Black, Hispanic or Latino/a/x, Indigenous, Middle Eastern or North African; (2) ethnic origins: North Africa, Sub-Saharan Africa, West Asia or Middle East, Pacific or Oceania, North America, Central America and Caribbean, and South America. There is also a gap in the prevalence (or risk) of allopurinol-induced SCARs in patients who tested positive for <em>HLA-B*58:01</em> genotyping. Although the results of the EuroSCAR study showed an increasing risk of SCARs in patients receiving ≥ 200 mg of allopurinol per day, our data did not facilitate investigating the association between allopurinol dosage and SCARs<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Our goal is to address these in the updated versions of this review.</p>
<p id="Par49">Findings from this review can support <em>HLA-B*58:01</em> screening and other preventive measures in people of Han Chinese, Korean, Thai, and Vietnamese descent due to the high prevalence of <em>HLA-B*58:01</em> genotyping. However, the decision to implement these policies may highly depend on the feasibility and relevant costs. A lack of alternative pharmacologic options to allopurinol can also mitigate the applicability of evidence from this review, as high-risk populations with hyperuricaemia or gout will either be undertreated or exposed to allopurinol.</p></section><section id="Sec32"><h3 class="pmc_sec_title">Potential biases in the review process</h3>
<p id="Par50">We followed a systematic approach to ensure replicability and mitigate biases in the review process<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. We searched and retrieved the studies from multiple sources with no restrictions on the language of publication. Each study was independently assessed for eligibility and risk of bias by at least 2 authors. Data were extracted using a standardised form. We pre-specified all analyses except for subgroup analysis of ethnicities, as this was not our primary objective. Since we did not have patient-specific data, we had to classify the subgroups using the dominant races and ethnic origins, which may have introduced some levels of bias from studies reporting multi-racial or multi-ethnic data. The threshold for excluding studies with a high risk of bias in the sensitivity analyses was also not widely recognised<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. The variability in <em>HLA-B*58:01</em> genotyping techniques might influence the detection of this allele in the original studies. The detection of SCARs can also involve score-based diagnostic criteria with some levels of uncertainty, which might cause misclassification bias.</p></section><section id="Sec33"><h3 class="pmc_sec_title">Agreements and disagreements with other studies or reviews</h3>
<p id="Par51">Although there are published and ongoing reviews of <em>HLA-B*58:01</em> genotyping and allopurinol-induced SCARs<sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>–<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>, only a few systematically investigated the epidemiology of this allele worldwide. There has been no meta-analysis to identify the prevalence of <em>HLA-B*58:01</em> genotyping in different sub-populations. The association between <em>HLA-B*58:01</em> genotyping and allopurinol-induced SCARs was consistent with other reviews<sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>,<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>. However, our findings revealed a stronger magnitude, especially in the Asian populations.</p></section></section><section id="Sec34"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par52">We found a higher prevalence of <em>HLA-B*58:01</em> genotyping in some Asian populations compared with the Whites. There is evidence to confirm a strong association between this allele and allopurinol-induced SCARs. Before initiating allopurinol for hyperuricaemia or gout treatment, people of Han Chinese, Korean, Thai, and Vietnamese descent should be screened for <em>HLA-B*58:01</em> genotyping. This screening measure should also be applied to other populations with evidence of a high prevalence of <em>HLA-B*58:01</em> genotyping. Further studies should target the under-reported races and ethnic origins to explore the prevalence of <em>HLA-B*58:01</em> genotyping. The risk of developing allopurinol-induced SCARs in patients who tested positive also needs to be addressed. To facilitate the adoption of screening and other preventive measures, cost-effectiveness analysis should be conducted whenever and wherever possible.</p></section><section id="Sec180"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12371011/bin/41598_2025_16062_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (5MB, pdf) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>AGEP</dt>
<dd><p id="Par2">Acute generalised exanthematous pustulosis</p></dd>
<dt>CI</dt>
<dd><p id="Par3">Confidence interval</p></dd>
<dt>DHS</dt>
<dd><p id="Par4">Drug hypersensitivity syndrome</p></dd>
<dt>DIHS</dt>
<dd><p id="Par5">Drug-induced hypersensitivity syndrome</p></dd>
<dt>DRESS</dt>
<dd><p id="Par6">Drug reaction with eosinophilia and systemic symptoms</p></dd>
<dt>EMM</dt>
<dd><p id="Par7">Erythema multiforme major</p></dd>
<dt>HLA</dt>
<dd><p id="Par8">Human leukocyte antigen</p></dd>
<dt>HSS</dt>
<dd><p id="Par9">Hypersensitivity syndrome</p></dd>
<dt>IQR</dt>
<dd><p id="Par10">Interquartile range</p></dd>
<dt>ISSN</dt>
<dd><p id="Par11">International Standard Serial Number</p></dd>
<dt>MPE</dt>
<dd><p id="Par12">Maculopapular eruption</p></dd>
<dt>NOS</dt>
<dd><p id="Par13">Newcastle–Ottawa Scale</p></dd>
<dt>OR</dt>
<dd><p id="Par14">Odds ratio</p></dd>
<dt>PRISMA</dt>
<dd><p id="Par15">Preferred reporting items for systematic reviews and meta-analyses</p></dd>
<dt>SCAR</dt>
<dd><p id="Par16">Severe cutaneous adverse reaction</p></dd>
<dt>SD</dt>
<dd><p id="Par17">Standard deviation</p></dd>
<dt>SJS</dt>
<dd><p id="Par18">Stevens–Johnson syndrome</p></dd>
<dt>SJS/TEN</dt>
<dd><p id="Par19">Stevens–Johnson/toxic epidermal necrolysis overlap syndrome</p></dd>
<dt>TEN</dt>
<dd><p id="Par20">Toxic epidermal necrolysis</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>H.T.P.: Conceptualisation, Methodology, Validation, Formal analysis, Investigation, Writing – original draft, Writing – review &amp; editing. M.H.T.: Conceptualisation, Methodology, Formal analysis, Investigation, Writing – original draft, Writing – review &amp; editing, Supervision, Project administration. T.-V.M.H.: Validation, Formal analysis, Investigation, Data, Writing – original draft, Writing – review &amp; editing. A.-H.N.: Formal analysis, Investigation, Data, Writing – original draft, Writing – review &amp; editing, Visualisation. M.-H.T.: Conceptualisation, Methodology, Validation, Formal analysis, Investigation, Data, Writing – original draft, Writing – review &amp; editing, Visualisation, Supervision, Project administration.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes3"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par53">HTP reported receiving speaking fees and travel reimbursement from Servier Vietnam Ltd and Pfizer Vietnam Ltd, grants from Servier Vietnam Ltd outside the submitted work. M-HT reported receiving travel reimbursement from Pfizer Vietnam Ltd, speaking fees and grants from Servier Vietnam Ltd outside the submitted work. Other authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Hong Tham Pham and Manh Hung Tran contributed equally to this work and share first authorship.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Halevy, S. et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. <em>J. Am. Acad. Dermatol.</em><strong>58</strong>, 25–32. 10.1016/j.jaad.2007.08.036 (2008).
</cite> [<a href="https://doi.org/10.1016/j.jaad.2007.08.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17919772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Halevy,%20S.%20et%20al.%20Allopurinol%20is%20the%20most%20common%20cause%20of%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis%20in%20Europe%20and%20Israel.%20J.%20Am.%20Acad.%20Dermatol.58,%2025%E2%80%9332.%2010.1016/j.jaad.2007.08.036%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Mockenhaupt, M. et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. <em>J. Invest. Dermatol.</em><strong>128</strong>, 35–44. 10.1038/sj.jid.5701033 (2008).
</cite> [<a href="https://doi.org/10.1038/sj.jid.5701033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17805350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mockenhaupt,%20M.%20et%20al.%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis:%20Assessment%20of%20medication%20risks%20with%20emphasis%20on%20recently%20marketed%20drugs.%20The%20EuroSCAR-study.%20J.%20Invest.%20Dermatol.128,%2035%E2%80%9344.%2010.1038/sj.jid.5701033%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Ramasamy, S. N. et al. Allopurinol hypersensitivity: A systematic review of all published cases, 1950–2012. <em>Drug Saf.</em><strong>36</strong>, 953–980. 10.1007/s40264-013-0084-0 (2013).
</cite> [<a href="https://doi.org/10.1007/s40264-013-0084-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23873481/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ramasamy,%20S.%20N.%20et%20al.%20Allopurinol%20hypersensitivity:%20A%20systematic%20review%20of%20all%20published%20cases,%201950%E2%80%932012.%20Drug%20Saf.36,%20953%E2%80%93980.%2010.1007/s40264-013-0084-0%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Stamp, L. K., Day, R. O. &amp; Yun, J. Allopurinol hypersensitivity: Investigating the cause and minimizing the risk. <em>Nat. Rev. Rheumatol.</em><strong>12</strong>, 235–242. 10.1038/nrrheum.2015.132 (2016).
</cite> [<a href="https://doi.org/10.1038/nrrheum.2015.132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26416594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stamp,%20L.%20K.,%20Day,%20R.%20O.%20&amp;%20Yun,%20J.%20Allopurinol%20hypersensitivity:%20Investigating%20the%20cause%20and%20minimizing%20the%20risk.%20Nat.%20Rev.%20Rheumatol.12,%20235%E2%80%93242.%2010.1038/nrrheum.2015.132%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Chung, W. H., Wang, C. W. &amp; Dao, R. L. Severe cutaneous adverse drug reactions. <em>J. Dermatol.</em><strong>43</strong>, 758–766. 10.1111/1346-8138.13430 (2016).
</cite> [<a href="https://doi.org/10.1111/1346-8138.13430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27154258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chung,%20W.%20H.,%20Wang,%20C.%20W.%20&amp;%20Dao,%20R.%20L.%20Severe%20cutaneous%20adverse%20drug%20reactions.%20J.%20Dermatol.43,%20758%E2%80%93766.%2010.1111/1346-8138.13430%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Khanna, D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. <em>Arthritis Care Res.</em><strong>64</strong>, 1431–1446. 10.1002/acr.21772 (2012).</cite> [<a href="https://doi.org/10.1002/acr.21772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3683400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23024028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khanna,%20D.%20et%20al.%202012%20American%20College%20of%20Rheumatology%20guidelines%20for%20management%20of%20gout.%20Part%201:%20Systematic%20nonpharmacologic%20and%20pharmacologic%20therapeutic%20approaches%20to%20hyperuricemia.%20Arthritis%20Care%20Res.64,%201431%E2%80%931446.%2010.1002/acr.21772%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Cao, Z. H. et al. HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese. <em>Pharmacogenomics</em><strong>13</strong>, 1193–1201. 10.2217/pgs.12.89 (2012).
</cite> [<a href="https://doi.org/10.2217/pgs.12.89" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22909208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao,%20Z.%20H.%20et%20al.%20HLA-B*58:01%20allele%20is%20associated%20with%20augmented%20risk%20for%20both%20mild%20and%20severe%20cutaneous%20adverse%20reactions%20induced%20by%20allopurinol%20in%20Han%20Chinese.%20Pharmacogenomics13,%201193%E2%80%931201.%2010.2217/pgs.12.89%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Cheng, L. et al. HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: A multicentre retrospective case-control clinical study. <em>Br. J. Dermatol.</em><strong>173</strong>, 555–558. 10.1111/bjd.13688 (2015).
</cite> [<a href="https://doi.org/10.1111/bjd.13688" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26104483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng,%20L.%20et%20al.%20HLA-B*58:01%20is%20strongly%20associated%20with%20allopurinol-induced%20severe%20cutaneous%20adverse%20reactions%20in%20Han%20Chinese%20patients:%20A%20multicentre%20retrospective%20case-control%20clinical%20study.%20Br.%20J.%20Dermatol.173,%20555%E2%80%93558.%2010.1111/bjd.13688%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Chiu, M. L. et al. Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong. <em>Br. J. Dermatol.</em><strong>167</strong>, 44–49. 10.1111/j.1365-2133.2012.10894.x (2012).
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.2012.10894.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22348415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chiu,%20M.%20L.%20et%20al.%20Association%20between%20HLA-B*58:01%20allele%20and%20severe%20cutaneous%20adverse%20reactions%20with%20allopurinol%20in%20Han%20Chinese%20in%20Hong%20Kong.%20Br.%20J.%20Dermatol.167,%2044%E2%80%9349.%2010.1111/j.1365-2133.2012.10894.x%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Cristallo, A. F. et al. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis. <em>Int. J. Immunogenet.</em><strong>38</strong>, 303–309. 10.1111/j.1744-313X.2011.01011.x (2011).
</cite> [<a href="https://doi.org/10.1111/j.1744-313X.2011.01011.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21545408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cristallo,%20A.%20F.%20et%20al.%20A%20study%20of%20HLA%20class%20I%20and%20class%20II%204-digit%20allele%20level%20in%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis.%20Int.%20J.%20Immunogenet.38,%20303%E2%80%93309.%2010.1111/j.1744-313X.2011.01011.x%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Gonçalo, M. et al. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population. <em>Br. J. Dermatol.</em><strong>169</strong>, 660–665. 10.1111/bjd.12389 (2013).
</cite> [<a href="https://doi.org/10.1111/bjd.12389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23600531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gon%C3%A7alo,%20M.%20et%20al.%20HLA-B*58:01%20is%20a%20risk%20factor%20for%20allopurinol-induced%20DRESS%20and%20Stevens-Johnson%20syndrome/toxic%20epidermal%20necrolysis%20in%20a%20Portuguese%20population.%20Br.%20J.%20Dermatol.169,%20660%E2%80%93665.%2010.1111/bjd.12389%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Kang, H. R. et al. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. <em>Pharmacogenet. Genomics</em><strong>21</strong>, 303–307. 10.1097/FPC.0b013e32834282b8 (2011).
</cite> [<a href="https://doi.org/10.1097/FPC.0b013e32834282b8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21301380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kang,%20H.%20R.%20et%20al.%20Positive%20and%20negative%20associations%20of%20HLA%20class%20I%20alleles%20with%20allopurinol-induced%20SCARs%20in%20Koreans.%20Pharmacogenet.%20Genomics21,%20303%E2%80%93307.%2010.1097/FPC.0b013e32834282b8%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Kaniwa, N. et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. <em>Pharmacogenomics</em><strong>9</strong>, 1617–1622. 10.2217/14622416.9.11.1617 (2008).
</cite> [<a href="https://doi.org/10.2217/14622416.9.11.1617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19018717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaniwa,%20N.%20et%20al.%20HLA-B%20locus%20in%20Japanese%20patients%20with%20anti-epileptics%20and%20allopurinol-related%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis.%20Pharmacogenomics9,%201617%E2%80%931622.%2010.2217/14622416.9.11.1617%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Sukasem, C. et al. HLA-B (*) 58:01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand. <em>Front. Pharmacol.</em><strong>7</strong>, 186. 10.3389/fphar.2016.00186 (2016).
</cite> [<a href="https://doi.org/10.3389/fphar.2016.00186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4947582/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27486401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sukasem,%20C.%20et%20al.%20HLA-B%20(*)%2058:01%20for%20allopurinol-induced%20cutaneous%20adverse%20drug%20reactions:%20Implication%20for%20clinical%20interpretation%20in%20Thailand.%20Front.%20Pharmacol.7,%20186.%2010.3389/fphar.2016.00186%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Tassaneeyakul, W. et al. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. <em>Pharmacogenet. Genomics</em><strong>19</strong>, 704–709. 10.1097/FPC.0b013e328330a3b8 (2009).
</cite> [<a href="https://doi.org/10.1097/FPC.0b013e328330a3b8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19696695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tassaneeyakul,%20W.%20et%20al.%20Strong%20association%20between%20HLA-B*5801%20and%20allopurinol-induced%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis%20in%20a%20Thai%20population.%20Pharmacogenet.%20Genomics19,%20704%E2%80%93709.%2010.1097/FPC.0b013e328330a3b8%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Tohkin, M. et al. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. <em>Pharmacogenomics J.</em><strong>13</strong>, 60–69. 10.1038/tpj.2011.41 (2013).
</cite> [<a href="https://doi.org/10.1038/tpj.2011.41" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21912425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tohkin,%20M.%20et%20al.%20A%20whole-genome%20association%20study%20of%20major%20determinants%20for%20allopurinol-related%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis%20in%20Japanese%20patients.%20Pharmacogenomics%20J.13,%2060%E2%80%9369.%2010.1038/tpj.2011.41%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Yun, J. et al. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01. <em>J. Immunol.</em><strong>192</strong>, 2984–2993. 10.4049/jimmunol.1302306 (2014).
</cite> [<a href="https://doi.org/10.4049/jimmunol.1302306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24591375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yun,%20J.%20et%20al.%20Oxypurinol%20directly%20and%20immediately%20activates%20the%20drug-specific%20T%20cells%20via%20the%20preferential%20use%20of%20HLA-B*58:01.%20J.%20Immunol.192,%202984%E2%80%932993.%2010.4049/jimmunol.1302306%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Lin, C. H. et al. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. <em>J. Allergy Clin. Immunol.</em><strong>135</strong>, 1063-1065.e1065. 10.1016/j.jaci.2014.09.041 (2015).
</cite> [<a href="https://doi.org/10.1016/j.jaci.2014.09.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25458913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20C.%20H.%20et%20al.%20Immunologic%20basis%20for%20allopurinol-induced%20severe%20cutaneous%20adverse%20reactions:%20HLA-B*58:01-restricted%20activation%20of%20drug-specific%20T%20cells%20and%20molecular%20interaction.%20J.%20Allergy%20Clin.%20Immunol.135,%201063-1065.e1065.%2010.1016/j.jaci.2014.09.041%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Ke, C. H. et al. Cost-effectiveness analysis for genotyping before allopurinol treatment to prevent severe cutaneous adverse drug reactions. <em>J. Rheumatol.</em><strong>44</strong>, 835–843. 10.3899/jrheum.151476 (2017).
</cite> [<a href="https://doi.org/10.3899/jrheum.151476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28365572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ke,%20C.%20H.%20et%20al.%20Cost-effectiveness%20analysis%20for%20genotyping%20before%20allopurinol%20treatment%20to%20prevent%20severe%20cutaneous%20adverse%20drug%20reactions.%20J.%20Rheumatol.44,%20835%E2%80%93843.%2010.3899/jrheum.151476%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Saokaew, S., Tassaneeyakul, W., Maenthaisong, R. &amp; Chaiyakunapruk, N. Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population. <em>PLoS ONE</em><strong>9</strong>, e94294. 10.1371/journal.pone.0094294 (2014).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0094294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3986079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24732692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saokaew,%20S.,%20Tassaneeyakul,%20W.,%20Maenthaisong,%20R.%20&amp;%20Chaiyakunapruk,%20N.%20Cost-effectiveness%20analysis%20of%20HLA-B*5801%20testing%20in%20preventing%20allopurinol-induced%20SJS/TEN%20in%20Thai%20population.%20PLoS%20ONE9,%20e94294.%2010.1371/journal.pone.0094294%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Jutkowitz, E., Dubreuil, M., Lu, N., Kuntz, K. M. &amp; Choi, H. K. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. <em>Semin. Arthritis Rheum.</em><strong>46</strong>, 594–600. 10.1016/j.semarthrit.2016.10.009 (2017).
</cite> [<a href="https://doi.org/10.1016/j.semarthrit.2016.10.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5403555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27916277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jutkowitz,%20E.,%20Dubreuil,%20M.,%20Lu,%20N.,%20Kuntz,%20K.%20M.%20&amp;%20Choi,%20H.%20K.%20The%20cost-effectiveness%20of%20HLA-B*5801%20screening%20to%20guide%20initial%20urate-lowering%20therapy%20for%20gout%20in%20the%20United%20States.%20Semin.%20Arthritis%20Rheum.46,%20594%E2%80%93600.%2010.1016/j.semarthrit.2016.10.009%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Duong, K. N. C., Nguyen, D. V., Chaiyakunapruk, N., Nelson, R. E. &amp; Malone, D. C. Cost-effectiveness of HLA-B*58:01 testing to prevent Stevens-Johnson syndrome/toxic epidermal necrolysis in Vietnam. <em>Pharmacogenomics</em><strong>24</strong>, 713–724. 10.2217/pgs-2023-0095 (2023).
</cite> [<a href="https://doi.org/10.2217/pgs-2023-0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11828023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37706247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duong,%20K.%20N.%20C.,%20Nguyen,%20D.%20V.,%20Chaiyakunapruk,%20N.,%20Nelson,%20R.%20E.%20&amp;%20Malone,%20D.%20C.%20Cost-effectiveness%20of%20HLA-B*58:01%20testing%20to%20prevent%20Stevens-Johnson%20syndrome/toxic%20epidermal%20necrolysis%20in%20Vietnam.%20Pharmacogenomics24,%20713%E2%80%93724.%2010.2217/pgs-2023-0095%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Plumpton, C. O., Alfirevic, A., Pirmohamed, M. &amp; Hughes, D. A. Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout. <em>Rheumatology</em><strong>56</strong>, 1729–1739. 10.1093/rheumatology/kex253 (2017).
</cite> [<a href="https://doi.org/10.1093/rheumatology/kex253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28957559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Plumpton,%20C.%20O.,%20Alfirevic,%20A.,%20Pirmohamed,%20M.%20&amp;%20Hughes,%20D.%20A.%20Cost%20effectiveness%20analysis%20of%20HLA-B*58:01%20genotyping%20prior%20to%20initiation%20of%20allopurinol%20for%20gout.%20Rheumatology56,%201729%E2%80%931739.%2010.1093/rheumatology/kex253%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Higgins, J. P. T. et al. <em>Cochrane Handbook for Systematic Reviews of Interventions</em> 2nd edn. (John Wiley &amp; Sons, 2019).</cite> [<a href="https://scholar.google.com/scholar_lookup?Higgins,%20J.%20P.%20T.%20et%20al.%20Cochrane%20Handbook%20for%20Systematic%20Reviews%20of%20Interventions%202nd%20edn.%20(John%20Wiley%20&amp;%20Sons,%202019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Pham, H. T., Hoang, T.-V. M., Tran, M.-H., Nguyen, A.-H. &amp; Tran, M. H. <em>HLA-B*58:01 prevalence and the association with allopurinol-induced serious cutaneous adverse reactions: A living systematic review and meta-analysis</em>. <a href="https://osf.io/qgmyx" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://osf.io/qgmyx</a> (2023).</cite> [<a href="https://doi.org/10.1038/s41598-025-16062-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12371011/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40841814/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. <em>BMJ</em><strong>372</strong>, n71. 10.1136/bmj.n71 (2021).
</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Page,%20M.%20J.%20et%20al.%20The%20PRISMA%202020%20statement:%20An%20updated%20guideline%20for%20reporting%20systematic%20reviews.%20BMJ372,%20n71.%2010.1136/bmj.n71%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Ford, M. E. &amp; Kelly, P. A. Conceptualizing and categorizing race and ethnicity in health services research. <em>Health Serv. Res.</em><strong>40</strong>, 1658–1675. 10.1111/j.1475-6773.2005.00449.x (2005).
</cite> [<a href="https://doi.org/10.1111/j.1475-6773.2005.00449.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1361221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16179001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ford,%20M.%20E.%20&amp;%20Kelly,%20P.%20A.%20Conceptualizing%20and%20categorizing%20race%20and%20ethnicity%20in%20health%20services%20research.%20Health%20Serv.%20Res.40,%201658%E2%80%931675.%2010.1111/j.1475-6773.2005.00449.x%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Wells, G. A. et al. <em>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses</em>. <a href="https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</a> (2013).</cite>
</li>
<li id="CR29">
<span class="label">29.</span><cite>Fahmy, O., Fahmy, U. A., Alhakamy, N. A. &amp; Khairul-Asri, M. G. Single-port versus multiple-port robot-assisted radical prostatectomy: A systematic review and meta-analysis. <em>J. Clin. Med.</em><strong>10</strong>, 5723. 10.3390/jcm10245723 (2021).
</cite> [<a href="https://doi.org/10.3390/jcm10245723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8703720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34945018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fahmy,%20O.,%20Fahmy,%20U.%20A.,%20Alhakamy,%20N.%20A.%20&amp;%20Khairul-Asri,%20M.%20G.%20Single-port%20versus%20multiple-port%20robot-assisted%20radical%20prostatectomy:%20A%20systematic%20review%20and%20meta-analysis.%20J.%20Clin.%20Med.10,%205723.%2010.3390/jcm10245723%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Egger, M., Davey Smith, G., Schneider, M. &amp; Minder, C. Bias in meta-analysis detected by a simple, graphical test. <em>BMJ</em><strong>315</strong>, 629–634. 10.1136/bmj.315.7109.629 (1997).
</cite> [<a href="https://doi.org/10.1136/bmj.315.7109.629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2127453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9310563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egger,%20M.,%20Davey%20Smith,%20G.,%20Schneider,%20M.%20&amp;%20Minder,%20C.%20Bias%20in%20meta-analysis%20detected%20by%20a%20simple,%20graphical%20test.%20BMJ315,%20629%E2%80%93634.%2010.1136/bmj.315.7109.629%20(1997)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Lin, L. et al. Empirical comparison of publication bias tests in meta-analysis. <em>J. Gen. Intern. Med.</em><strong>33</strong>, 1260–1267. 10.1007/s11606-018-4425-7 (2018).
</cite> [<a href="https://doi.org/10.1007/s11606-018-4425-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6082203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29663281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20L.%20et%20al.%20Empirical%20comparison%20of%20publication%20bias%20tests%20in%20meta-analysis.%20J.%20Gen.%20Intern.%20Med.33,%201260%E2%80%931267.%2010.1007/s11606-018-4425-7%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R. &amp; Rushton, L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. <em>J. Clin. Epidemiol.</em><strong>61</strong>, 991–996. 10.1016/j.jclinepi.2007.11.010 (2008).
</cite> [<a href="https://doi.org/10.1016/j.jclinepi.2007.11.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18538991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peters,%20J.%20L.,%20Sutton,%20A.%20J.,%20Jones,%20D.%20R.,%20Abrams,%20K.%20R.%20&amp;%20Rushton,%20L.%20Contour-enhanced%20meta-analysis%20funnel%20plots%20help%20distinguish%20publication%20bias%20from%20other%20causes%20of%20asymmetry.%20J.%20Clin.%20Epidemiol.61,%20991%E2%80%93996.%2010.1016/j.jclinepi.2007.11.010%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Viechtbauer, W. Conducting meta-analyses in R with the metafor Package. <em>J. Stat. Soft.</em><strong>36</strong>, 1–48. 10.18637/jss.v036.i03 (2010).</cite> [<a href="https://scholar.google.com/scholar_lookup?Viechtbauer,%20W.%20Conducting%20meta-analyses%20in%20R%20with%20the%20metafor%20Package.%20J.%20Stat.%20Soft.36,%201%E2%80%9348.%2010.18637/jss.v036.i03%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Dayimu, A. <em>Create Flexible Forest Plot</em>. <a href="https://cran.r-project.org/web/packages/forestploter/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cran.r-project.org/web/packages/forestploter/index.html</a> (2023).</cite>
</li>
<li id="CR35">
<span class="label">35.</span><cite>Do, T. Q. N. et al. Association between HLA B*5801 and Allopurinol-induced severe cutaneous adverse drug reactions in BachMai Hospital. <em>Vietnam J. Prev. Med.</em><strong>25</strong>, 396–400 (2015).</cite> [<a href="https://scholar.google.com/scholar_lookup?Do,%20T.%20Q.%20N.%20et%20al.%20Association%20between%20HLA%20B*5801%20and%20Allopurinol-induced%20severe%20cutaneous%20adverse%20drug%20reactions%20in%20BachMai%20Hospital.%20Vietnam%20J.%20Prev.%20Med.25,%20396%E2%80%93400%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Lonjou, C. et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. <em>Pharmacogenet. Genomics</em><strong>18</strong>, 99–107. 10.1097/FPC.0b013e3282f3ef9c (2008).
</cite> [<a href="https://doi.org/10.1097/FPC.0b013e3282f3ef9c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18192896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lonjou,%20C.%20et%20al.%20A%20European%20study%20of%20HLA-B%20in%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis%20related%20to%20five%20high-risk%20drugs.%20Pharmacogenet.%20Genomics18,%2099%E2%80%93107.%2010.1097/FPC.0b013e3282f3ef9c%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Hung, S. I. et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. <em>Proc. Natl. Acad. Sci. U. S. A.</em><strong>102</strong>, 4134–4139. 10.1073/pnas.0409500102 (2005).
</cite> [<a href="https://doi.org/10.1073/pnas.0409500102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC554812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15743917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hung,%20S.%20I.%20et%20al.%20HLA-B*5801%20allele%20as%20a%20genetic%20marker%20for%20severe%20cutaneous%20adverse%20reactions%20caused%20by%20allopurinol.%20Proc.%20Natl.%20Acad.%20Sci.%20U.%20S.%20A.102,%204134%E2%80%934139.%2010.1073/pnas.0409500102%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Do, M. D. et al. Risk factors for cutaneous reactions to allopurinol in Kinh Vietnamese: Results from a case-control study. <em>Arthritis Res. Ther.</em><strong>22</strong>, 182. 10.1186/s13075-020-02273-1 (2020).
</cite> [<a href="https://doi.org/10.1186/s13075-020-02273-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7397637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32746911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Do,%20M.%20D.%20et%20al.%20Risk%20factors%20for%20cutaneous%20reactions%20to%20allopurinol%20in%20Kinh%20Vietnamese:%20Results%20from%20a%20case-control%20study.%20Arthritis%20Res.%20Ther.22,%20182.%2010.1186/s13075-020-02273-1%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Ng, C. Y. et al. Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions. <em>J. Invest. Dermatol.</em><strong>136</strong>, 1373–1381. 10.1016/j.jid.2016.02.808 (2016).
</cite> [<a href="https://doi.org/10.1016/j.jid.2016.02.808" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26996548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ng,%20C.%20Y.%20et%20al.%20Impact%20of%20the%20HLA-B(*)58:01%20allele%20and%20renal%20impairment%20on%20allopurinol-induced%20cutaneous%20adverse%20reactions.%20J.%20Invest.%20Dermatol.136,%201373%E2%80%931381.%2010.1016/j.jid.2016.02.808%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Saksit, N. et al. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. <em>Pharmacogenet. Genomics</em><strong>27</strong>, 255–263. 10.1097/fpc.0000000000000285 (2017).
</cite> [<a href="https://doi.org/10.1097/FPC.0000000000000285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28509689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saksit,%20N.%20et%20al.%20Risk%20factors%20of%20allopurinol-induced%20severe%20cutaneous%20adverse%20reactions%20in%20a%20Thai%20population.%20Pharmacogenet.%20Genomics27,%20255%E2%80%93263.%2010.1097/fpc.0000000000000285%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Nguyen, D. V. et al. Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese. <em>Pharmacogenomics</em><strong>22</strong>, 1–12. 10.2217/pgs-2019-0146 (2021).
</cite> [<a href="https://doi.org/10.2217/pgs-2019-0146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33356553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen,%20D.%20V.%20et%20al.%20Genetic%20susceptibilities%20and%20prediction%20modeling%20of%20carbamazepine%20and%20allopurinol-induced%20severe%20cutaneous%20adverse%20reactions%20in%20Vietnamese.%20Pharmacogenomics22,%201%E2%80%9312.%2010.2217/pgs-2019-0146%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Pham, T. T. H. et al. Allopurinol-induced severe cutaneous adverse reactions in Vietnamese: The role of HLA alleles and other risk factors. <em>Pharmacogenomics</em><strong>23</strong>, 303–313. 10.2217/pgs-2021-0156 (2022).
</cite> [<a href="https://doi.org/10.2217/pgs-2021-0156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35187976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pham,%20T.%20T.%20H.%20et%20al.%20Allopurinol-induced%20severe%20cutaneous%20adverse%20reactions%20in%20Vietnamese:%20The%20role%20of%20HLA%20alleles%20and%20other%20risk%20factors.%20Pharmacogenomics23,%20303%E2%80%93313.%2010.2217/pgs-2021-0156%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Bardin, T. et al. FRI0227 Risk factors for skin reactions to allopurinol in the kinh population of vietnam. <em>Ann. Rheum. Dis.</em><strong>77</strong>, 655. 10.1136/annrheumdis-2018-eular.6104 (2018).</cite> [<a href="https://scholar.google.com/scholar_lookup?Bardin,%20T.%20et%20al.%20FRI0227%20Risk%20factors%20for%20skin%20reactions%20to%20allopurinol%20in%20the%20kinh%20population%20of%20vietnam.%20Ann.%20Rheum.%20Dis.77,%20655.%2010.1136/annrheumdis-2018-eular.6104%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Do, A. D., Le Gia, H. L., Do, M. D. &amp; Mai, T. P. The prevalence of allele HLA-B*58:01 in Vietnamese gout patients with allopurinol-induced skin reactions. <em>Ho Chi Minh City J. Med.</em><strong>23</strong>, 80–84 (2019).</cite> [<a href="https://scholar.google.com/scholar_lookup?Do,%20A.%20D.,%20Le%20Gia,%20H.%20L.,%20Do,%20M.%20D.%20&amp;%20Mai,%20T.%20P.%20The%20prevalence%20of%20allele%20HLA-B*58:01%20in%20Vietnamese%20gout%20patients%20with%20allopurinol-induced%20skin%20reactions.%20Ho%20Chi%20Minh%20City%20J.%20Med.23,%2080%E2%80%9384%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Jung, J. W. et al. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency. <em>Nephrol. Dial. Transplant.</em><strong>26</strong>, 3567–3572. 10.1093/ndt/gfr060 (2011).
</cite> [<a href="https://doi.org/10.1093/ndt/gfr060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21393610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jung,%20J.%20W.%20et%20al.%20HLA-B58%20can%20help%20the%20clinical%20decision%20on%20starting%20allopurinol%20in%20patients%20with%20chronic%20renal%20insufficiency.%20Nephrol.%20Dial.%20Transplant.26,%203567%E2%80%933572.%2010.1093/ndt/gfr060%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Low, D. E. et al. HLA-B*58: 01 association in allopurinol-induced severe cutaneous adverse reactions: The implication of ethnicity and clinical phenotypes in multiethnic Malaysia. <em>Pharmacogenet. Genomics</em><strong>30</strong>, 153–160. 10.1097/fpc.0000000000000408 (2020).
</cite> [<a href="https://doi.org/10.1097/FPC.0000000000000408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32433341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Low,%20D.%20E.%20et%20al.%20HLA-B*58:%2001%20association%20in%20allopurinol-induced%20severe%20cutaneous%20adverse%20reactions:%20The%20implication%20of%20ethnicity%20and%20clinical%20phenotypes%20in%20multiethnic%20Malaysia.%20Pharmacogenet.%20Genomics30,%20153%E2%80%93160.%2010.1097/fpc.0000000000000408%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Niihara, H. et al. HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population. <em>J. Dermatol. Sci.</em><strong>71</strong>, 150–152. 10.1016/j.jdermsci.2013.04.013 (2013).
</cite> [<a href="https://doi.org/10.1016/j.jdermsci.2013.04.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23669020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Niihara,%20H.%20et%20al.%20HLA-B*58:01%20strongly%20associates%20with%20allopurinol-induced%20adverse%20drug%20reactions%20in%20a%20Japanese%20sample%20population.%20J.%20Dermatol.%20Sci.71,%20150%E2%80%93152.%2010.1016/j.jdermsci.2013.04.013%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Park, H. J. et al. HLA allele frequencies in 5802 Koreans: Varied allele types associated with SJS/TEN according to culprit drugs. <em>Yonsei Med. J.</em><strong>57</strong>, 118–126. 10.3349/ymj.2016.57.1.118 (2016).
</cite> [<a href="https://doi.org/10.3349/ymj.2016.57.1.118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4696942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26632391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Park,%20H.%20J.%20et%20al.%20HLA%20allele%20frequencies%20in%205802%20Koreans:%20Varied%20allele%20types%20associated%20with%20SJS/TEN%20according%20to%20culprit%20drugs.%20Yonsei%20Med.%20J.57,%20118%E2%80%93126.%2010.3349/ymj.2016.57.1.118%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Yu, K. H., Yu, C. Y. &amp; Fang, Y. F. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: An updated systematic review and meta-analysis. <em>Int. J. Rheum. Dis.</em><strong>20</strong>, 1057–1071. 10.1111/1756-185x.13143 (2017).
</cite> [<a href="https://doi.org/10.1111/1756-185X.13143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28857441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu,%20K.%20H.,%20Yu,%20C.%20Y.%20&amp;%20Fang,%20Y.%20F.%20Diagnostic%20utility%20of%20HLA-B*5801%20screening%20in%20severe%20allopurinol%20hypersensitivity%20syndrome:%20An%20updated%20systematic%20review%20and%20meta-analysis.%20Int.%20J.%20Rheum.%20Dis.20,%201057%E2%80%931071.%2010.1111/1756-185x.13143%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Wu, R. et al. Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: Evidence from 21 pharmacogenetic studies. <em>Oncotarget</em><strong>7</strong>, 81870–81879. 10.18632/oncotarget.13250 (2016).
</cite> [<a href="https://doi.org/10.18632/oncotarget.13250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5348437/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27835909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu,%20R.%20et%20al.%20Impact%20of%20HLA-B*58:01%20allele%20and%20allopurinol-induced%20cutaneous%20adverse%20drug%20reactions:%20Evidence%20from%2021%20pharmacogenetic%20studies.%20Oncotarget7,%2081870%E2%80%9381879.%2010.18632/oncotarget.13250%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Somkrua, R., Eickman, E. E., Saokaew, S., Lohitnavy, M. &amp; Chaiyakunapruk, N. Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. <em>BMC Med. Genet.</em><strong>12</strong>, 118. 10.1186/1471-2350-12-118 (2011).
</cite> [<a href="https://doi.org/10.1186/1471-2350-12-118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3189112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21906289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Somkrua,%20R.,%20Eickman,%20E.%20E.,%20Saokaew,%20S.,%20Lohitnavy,%20M.%20&amp;%20Chaiyakunapruk,%20N.%20Association%20of%20HLA-B*5801%20allele%20and%20allopurinol-induced%20Stevens%20Johnson%20syndrome%20and%20toxic%20epidermal%20necrolysis:%20A%20systematic%20review%20and%20meta-analysis.%20BMC%20Med.%20Genet.12,%20118.%2010.1186/1471-2350-12-118%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12371011/bin/41598_2025_16062_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (5MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-16062-w"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_16062.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (6.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371011/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371011/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371011%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371011/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371011/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371011/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841814/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371011/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841814/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371011/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371011/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="cDPoA2zjMOYczYbiZZatuZISy0dDS7gst8r9TK2SaLfVER8KQVyMX7LMZiLS7fbb">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
